Lv31
380 积分 2025-08-25 加入
Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue
3天前
已完结
Reevaluating HER2-null breast cancer using an enhanced HER2 immunohistochemistry protocol
3天前
已完结
[Comparative study of three different decalcifying solutions in bone metastasis specimens with breast cancer]
3天前
已完结
Reevaluating HER2-null breast cancer using an enhanced HER2 immunohistochemistry protocol
3天前
已完结
Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
3天前
已完结
Navigating the HER2-Low Paradigm in Breast Oncology: New Standards, Future Horizons
6天前
已完结
HER2-targeted therapies beyond breast cancer — an update
7天前
已完结
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for previously untreated locally recurrent inoperable or metastatic triple-negative breast cancer (KEYNOTE-355): a randomised, placebo-controlled, double-blind, phase 3 clinical trial
18天前
已完结
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
19天前
已完结
Breast cancer surgery: an historical narrative. Part I. From prehistoric times to Renaissance
1个月前
已完结
皖公网安备34019202002308
